{"ok":true,"nota":{"id":"bf2587e2504e2f39","slug":"logran-fabricar-en-serie-vesiculas-celulares-con-calidad-de-medicament-bf2587","titulo":"Logran fabricar en serie vesículas celulares con calidad de medicamento para futuras terapias","resumen":"Investigadores del IGTP y del Banco de Sangre y Tejidos de Cataluña desarrollaron una plataforma semiautomatizada que produce lotes de vesículas extracelulares con calidad farmacéutica y consistente entre lotes. Validaron el proceso como paso previo a su uso clínico.","fuente":"phys","fuenteNombre":"Phys.org","color":"#2b5c8a","autor":"","url":"https://phys.org/news/2026-11-semiautomated-platform-batches-extracellular-vesicles.html","imagen":"https://scx1.b-cdn.net/csz/news/tmb/2026/new-manufacturing-plat.jpg","tema":"ciencia","subtemas":["vesiculas extracelulares","medicina regenerativa","produccion farmaceutica","terapias celulares","biotecnologia"],"entidades":["IGTP","Banco de Sangre y Tejidos","Cataluña"],"formato":"dato","entretenimiento":false,"pubTs":"2026-11-04T00:20:04.000Z","indexTs":"2026-11-04T00:22:57.633Z","hash":"5a26b3b08fa458c009248ecdc500a8ec5d21c52ee879c506f7b4a853342542a1","tsa":{"time":"Nov  4 00:23:06 2026 GMT","provider":"freetsa.org","sobre":"sello"},"stats":{"views":0,"likes":0,"clicks":0,"dwell":0},"tipo":"normal","registro":"hallazgo","porQueImporta":"Hasta ahora, producir estas vesículas en cantidades y con calidad uniforme era el gran cuello de botella para probarlas en pacientes. Que el proceso ya cumpla estándares farmacéuticos acerca la posibilidad de que una terapia regenerativa llegue algún día a un hospital, aunque todavía falta mucho para eso. Lo que se valida en el laboratorio es la fabricación, no la eficacia en personas, y esa diferencia pesa mucho.","quienFirma":"Instituto de Investigación Germans Trias i Pujol (IGTP) y Banco de Sangre y Tejidos (BST), Cataluña","confianza":"revisado","consulta":null},"sello":{"hash":"5a26b3b08fa458c009248ecdc500a8ec5d21c52ee879c506f7b4a853342542a1","sello":"7162e8156d58e74c926c19f45766bb0af3468356ad20feb1e0aa61771b537a3a","beacon":{"drand":{"cadena":"8990e7a9aaed2ffed73dbd7092123d6f289930540d7651336225dc172e51b2ce","ronda":6610692,"aleatorio":"c9fd2c303e6e05a21d09654d4db6310077253ed6bb3f0c6605f9b51be7702715","tiempo":"2026-11-04T00:23:00.000Z"},"nist":{"cadena":2,"pulso":2012279,"salida":"1CCBE7D6690C39A8046D0E94C53EC6769E23AA626A4149B1DBEAA4E440D6D58EE4F8F34007EA72ED4F06ACBDFCAB32FA69133CACC4FA13CFAE9265680BF3AED5","tiempo":"2026-11-04T00:21:00.000Z"},"noAntes":"2026-11-04T00:23:00.000Z"},"verificacion":{"drand":true,"nist":true},"tsa":{"time":"Nov  4 00:23:06 2026 GMT","provider":"freetsa.org","sobre":"sello"},"original":{"titulo":"Semiautomated platform delivers consistent batches of extracellular vesicles for potential regenerative therapies","descripcion":"A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Blood and Tissue Bank (BST) has developed and validated a manufacturing platform for extracellular vesicles that meets pharmaceutical quality requirements, marking a key step toward their clinical application.","pubDate":"Tue, 03 Nov 2026 19:20:04 EST","url":"https://phys.org/news/2026-11-semiautomated-platform-batches-extracellular-vesicles.html"},"indexado":"2026-11-04T00:22:57.633Z"}}